Business Context and Reporting Period
This Form 8-K was filed by Millendo Therapeutics, Inc. on February 7, 2019, reporting events occurring on February 1, 2019. The filing details the entry into a new material definitive agreement for corporate headquarters and the amendment of an existing lease.
Key Financial Metrics and Obligations
The filing does not provide revenue, profit, cash flow, or margin data. It focuses on specific lease obligations:
- New Headquarters Lease: Approximately 11,000 square feet at 110 Miller Avenue, Ann Arbor, Michigan.
- New Lease Term: Five years, commencing seven days after delivery (anticipated April 1, 2019).
- New Lease Rent: $31,166.67 per month for the first year, increasing by 3% annually.
- Renewal Options: Two options to extend for five years each, with 3% annual rent increases.
- Tenant Improvement Allowance: $121,000 provided by the landlord.
- Current Headquarters Extension: Lease at 301 N. Main Street extended through March 31, 2019, at $11,720 per month.
Material Changes
The primary material change is the transition of corporate headquarters. The company is moving from its current location (301 N. Main Street) to a new facility (110 Miller Avenue) in the first half of 2019. This involves a significant increase in monthly base rent from $11,720 to approximately $31,167 upon occupancy of the new premises.
Outlook and Management Commentary
Management anticipates occupying the new premises in the first half of 2019. The new lease includes a month-to-month renewal option for the current headquarters following March 31, 2019, providing flexibility during the transition. No specific financial guidance or risk factors beyond the standard lease obligations were disclosed in this report.
Investor Verification Checklist
- Verify the exact delivery date of the new premises to confirm the start of the lease term and rent obligations.
- Confirm the total cost of the move and any capital expenditures required beyond the $121,000 landlord allowance.
- Review the full text of the Lease Agreement (Exhibit 10.1) for termination clauses or additional operating expense responsibilities.
- Assess the impact of the increased monthly rent on the company's cash burn rate given its pre-revenue status.